Verici Dx plc (LON:VRCI – Get Free Report)’s stock price fell 9.6% during trading on Thursday . The company traded as low as GBX 2 ($0.03) and last traded at GBX 2.26 ($0.03). 2,428,404 shares changed hands during mid-day trading, an increase of 242% from the average session volume of 709,650 shares. The stock had previously closed at GBX 2.50 ($0.03).
Verici Dx Price Performance
The company has a current ratio of 4.54, a quick ratio of 8.49 and a debt-to-equity ratio of 4.64. The stock has a fifty day simple moving average of GBX 3.47 and a two-hundred day simple moving average of GBX 4.05. The company has a market cap of £6.86 million, a PE ratio of -1.31 and a beta of 1.59.
About Verici Dx
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Featured Articles
- Five stocks we like better than Verici Dx
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Investing in the High PE Growth Stocks
- Alphabet’s Officially In A Bear Market—Time To Buy?
- What to Know About Investing in Penny Stocks
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
